Trials / Completed
CompletedNCT03752502
Effects of Cerebral and Peripheral Electrical Stimulation on Conditioned Pain Modulation in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Universidade Federal do Piauí · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The Neuromatrix pain model and new findings on pain chronification process point to a greater efficacy of treatments that address central and peripheral rather than only peripheral structures. Both cerebral and peripheral electrical stimulations can modulate brain areas involved in pain processing. However, their effects on pain modulation systems and clinical outcomes are lacking. This study aims to investigate the efficacy of transcranial direct current stimulation (tDCS) and peripheral electrical stimulation (PES) alone as well tDCS combined with PES on pressure pain threshold and conditioned pain modulation in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transcranial direct current stimulation (tDCS) | Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results. |
| PROCEDURE | Peripheral electrical stimulation (PES) | Peripheral electrical stimulation (PES) activates a complex neural network involving a series of neurotransmitters and receptors capable of promoting segmental and extrasegmental analgesia. |
| PROCEDURE | Sham tDCS | Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results. |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-11-30
- Completion
- 2021-11-27
- First posted
- 2018-11-26
- Last updated
- 2023-11-28
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03752502. Inclusion in this directory is not an endorsement.